BC

Boxer Capital Portfolio holdings

AUM $2.04B
1-Year Return 108.35%
This Quarter Return
+5.57%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$1.88B
AUM Growth
-$278M
Cap. Flow
-$96.7M
Cap. Flow %
-5.15%
Top 10 Hldgs %
47.5%
Holding
84
New
5
Increased
6
Reduced
10
Closed
11

Top Buys

1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$52.3M
2
XBI icon
SPDR S&P Biotech ETF
XBI
$36.5M
3
IMVT icon
Immunovant
IMVT
$28.8M
4
PRTA icon
Prothena Corp
PRTA
$15.7M
5
ABOS icon
Acumen Pharmaceuticals
ABOS
$9.16M

Top Sells

1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$146M
2
ETNB icon
89bio
ETNB
$39.8M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$32.5M
4
CABA icon
Cabaletta Bio
CABA
$6.97M
5
IRON icon
Disc Medicine
IRON
$5.77M

Sector Composition

1 Healthcare 98.05%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AXSM icon
26
Axsome Therapeutics
AXSM
$6.25B
$28M 1.49%
400,000
– –
EXEL icon
27
Exelixis
EXEL
$10.2B
$25.1M 1.34%
1,150,000
– –
ANAB icon
28
AnaptysBio
ANAB
$613M
$23.3M 1.24%
1,300,000
– –
SAGE
29
DELISTED
Sage Therapeutics
SAGE
$22.5M 1.2%
1,094,000
– –
VKTX icon
30
Viking Therapeutics
VKTX
$3.03B
$22.1M 1.18%
2,000,000
– –
XENE icon
31
Xenon Pharmaceuticals
XENE
$3.02B
$20.5M 1.09%
600,000
– –
ITOS
32
DELISTED
iTeos Therapeutics
ITOS
$19.8M 1.05%
1,804,058
-350,000
-16% -$3.83M
PMVP icon
33
PMV Pharmaceuticals
PMVP
$77.4M
$19.4M 1.03%
3,163,795
– –
IOVA icon
34
Iovance Biotherapeutics
IOVA
$901M
$16.9M 0.9%
3,705,133
– –
PNT
35
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$16.7M 0.89%
2,500,000
– –
KALV icon
36
KalVista Pharmaceuticals
KALV
$796M
$15.9M 0.85%
1,650,000
– –
RLAY icon
37
Relay Therapeutics
RLAY
$710M
$15.3M 0.81%
1,819,132
– –
MDGL icon
38
Madrigal Pharmaceuticals
MDGL
$9.65B
$14.6M 0.78%
100,000
– –
DAWN icon
39
Day One Biopharmaceuticals
DAWN
$773M
$14.6M 0.78%
1,189,943
– –
ORIC icon
40
Oric Pharmaceuticals
ORIC
$1.06B
$10.5M 0.56%
1,732,571
– –
CGEM icon
41
Cullinan Oncology
CGEM
$413M
$9.72M 0.52%
1,074,082
– –
NRIX icon
42
Nurix Therapeutics
NRIX
$758M
$9.63M 0.51%
1,224,892
– –
ABOS icon
43
Acumen Pharmaceuticals
ABOS
$87.2M
$9.16M 0.49%
+2,206,983
New +$9.16M
ZNTL icon
44
Zentalis Pharmaceuticals
ZNTL
$126M
$9.03M 0.48%
450,000
– –
ASND icon
45
Ascendis Pharma
ASND
$12.5B
$8.9M 0.47%
95,000
– –
ELVN icon
46
Enliven Therapeutics
ELVN
$1.19B
$8.83M 0.47%
646,058
-64,586
-9% -$882K
PRLD icon
47
Prelude Therapeutics
PRLD
$69.6M
$7.71M 0.41%
2,495,018
– –
RNA icon
48
Avidity Biosciences
RNA
$6.48B
$7.15M 0.38%
1,121,327
– –
GERN icon
49
Geron
GERN
$893M
$6.36M 0.34%
3,000,000
– –
GOSS icon
50
Gossamer Bio
GOSS
$668M
$5.41M 0.29%
6,497,700
+3,160,772
+95% +$2.63M
1
2
3 4